Related Experiment Video

Updated: Jul 2, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

SOCS2: inhibitor of JAK2V617F-mediated signal transduction

H Quentmeier1, R Geffers, E Jost

  • 1DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany. hqu@dsmz.de

Leukemia
|September 5, 2008
PubMed

Insights

Activating Janus kinase 2 (JAK2) mutations in myeloproliferative disorders (MPDs) require SOCS2 gene inactivation for cytokine independence. Epigenetic silencing of SOCS2, a JAK2 pathway inhibitor, contributes to MPD development.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Janus kinase 2 (JAK2)V617F mutations are prevalent in myeloproliferative disorders (MPDs) and myelodysplastic syndromes (MDSs).
  • The role of JAK2V617F in conferring cytokine independence in MPD cells is not fully understood.
  • Suppressor of cytokine signaling 2 (SOCS2) is a known inhibitor of the JAK/STAT pathway.

Purpose of the Study:

  • To investigate the role of SOCS2 in JAK2V617F-driven cytokine independence in MPD cell lines.
  • To explore the mechanism of SOCS2 regulation, including epigenetic modifications.
  • To determine if SOCS2 downregulation is a critical step in MPD pathogenesis.

Main Methods:

  • Utilized JAK2V617F-mutated and wild-type MPD/MDS cell lines.
  • Assessed JAK2/STAT5 activation in response to cytokines.
  • Quantified SOCS2 expression levels.
  • Performed SOCS2 knockdown experiments.
  • Analyzed SOCS2 promoter methylation in cell lines and patient samples.

Main Results:

  • Two of four JAK2V617F-mutated cell lines exhibited cytokine independence, challenging the sole reliance on JAK2V617F activation.
  • Cytokine independence correlated inversely with SOCS2 expression.
  • SOCS2 knockdown induced constitutive STAT5 phosphorylation in JAK2V617F cells.
  • SOCS2 hypermethylation was observed in a cytokine-independent cell line and MPD patients, associated with reduced transcription factor binding.

Conclusions:

  • Cytokine independence in MPD cells likely involves a two-step mechanism: JAK2V617F activation and SOCS2 inactivation.
  • Epigenetic downregulation of SOCS2, via hypermethylation, is a potential key mechanism in MPD development.
  • SOCS2 acts as a crucial negative regulator of JAK2V617F signaling.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...